General correspondence: A challenge to the claims that fludarabine and cyclophosphamide is the new standard treatment for chronic lymphocytic leukaemia

I. Haines; P. Elliott; R. Stanley

doi:10.1111/j.1445-5994.2009.01905.x

General correspondence: A challenge to the claims that fludarabine and cyclophosphamide is the new standard treatment for chronic lymphocytic leukaemia

I. Haines, P. Elliott, R. Stanley

Research output: Contribution to journal › Letter › Other › peer-review

Original language	English
Pages (from-to)	269-271
Number of pages	3
Journal	Internal Medicine Journal
Volume	39
Issue number	4
DOIs	https://doi.org/10.1111/j.1445-5994.2009.01905.x
Publication status	Published - Apr 2009

Access to Document

10.1111/j.1445-5994.2009.01905.x

Cite this

@article{6a78815d493748e4b7924aaef2a26671,

title = "General correspondence: A challenge to the claims that fludarabine and cyclophosphamide is the new standard treatment for chronic lymphocytic leukaemia",

author = "I. Haines and P. Elliott and R. Stanley",

year = "2009",

month = apr,

doi = "10.1111/j.1445-5994.2009.01905.x",

language = "English",

volume = "39",

pages = "269--271",

journal = "Internal Medicine Journal",

issn = "1444-0903",

publisher = "Wiley-Blackwell",

number = "4",

}

TY - JOUR

T1 - General correspondence

T2 - A challenge to the claims that fludarabine and cyclophosphamide is the new standard treatment for chronic lymphocytic leukaemia

AU - Haines, I.

AU - Elliott, P.

AU - Stanley, R.

PY - 2009/4

Y1 - 2009/4

UR - http://www.scopus.com/inward/record.url?scp=65349111851&partnerID=8YFLogxK

U2 - 10.1111/j.1445-5994.2009.01905.x

DO - 10.1111/j.1445-5994.2009.01905.x

M3 - Letter

AN - SCOPUS:65349111851

SN - 1444-0903

VL - 39

SP - 269

EP - 271

JO - Internal Medicine Journal

JF - Internal Medicine Journal

IS - 4

ER -

General correspondence: A challenge to the claims that fludarabine and cyclophosphamide is the new standard treatment for chronic lymphocytic leukaemia

Access to Document

Other files and links

Cite this